Skeletal muscle is a key organ of mammalian energy metabolism, and its mitochondria are multifunction organelles that are targets of dietary bioactive compounds. The goal of this work was to examine the regulation of mitochondrial dynamics, functionality and cell energy parameters using docosahexaenoic acid (DHA), epigallocatechin gallate (EGCG) and a combination of both in L6 myocytes. Compounds (at 25 μM) were incubated for 4 h. Cells cultured with DHA displayed less oxygen consumption with higher ADP/ATP ratio levels concomitant with downregulation of Cox and Ant1 gene expression. The disruption of energetic homeostasis by DHA, increases intracellular reactive oxygen species (ROS) levels and decreases mitochondrial membrane potential. The defence mechanism to counteract the excess of ROS production was by the upregulation of Ucp2, Ucp3 and MnSod gene expression. Moreover myocytes cultured with DHA had a higher mitochondrial mass with a higher proportion of large and elongated mitochondria, whereas the fission genes Drp1 and Fiss1 and the fusion gene Mfn2 were downregulated. In myocytes co-incubated with DHA and EGCG, ROS levels and the adenosine diphosphate (ADP)/adenosine triphosphate (ATP) ratio were similar to untreated myocytes and the decrease of oxygen consumption, higher mitochondrial mass and the overexpression of Ucp2 and Ucp3 genes were similar to the DHA-treated cells with also a higher amount of mitochondrial deoxyribonucleic acid (DNA), and reduced Drp1 and Fiss1 gene expression levels. In conclusion the addition of EGCG to DHA returned the cells to the control conditions in terms of mitochondrial morphology, energy and redox status, which were unbalanced in the DHA-treated myocytes.
Introduction
Mitochondria are ubiquitous organelles in eukaryotic cells whose primary functions are to generate energy, regulate the cellular redox state and calcium homeostasis, and initiate cellular apoptosis [1] . In addition, mitochondria are the main intracellular source and immediate target of reactive oxygen species (ROS), which are continuously generated as byproducts of aerobic metabolism in mammalian cells. Thus, mitochondria play a pivotal role in the determination of the life and death of the mammalian cell [2] . The size, shape, and abundance of mitochondria vary dramatically in different cell types and may change under different energy demands and physiological environmental conditions [3] . In many cell types, especially muscle fibres, mitochondria form tubular structures or networks [4] . Increasing evidence, suggests that mitochondrial structure determines mitochondrial function [5] including substrate metabolism and mitochondrial bioenergetics. Mitochondria are highly dynamic organelles with constant fusion and fission events mediated by conserved cellular machineries. The frequencies of these fusion and fission events are balanced to maintain the overall morphology of the mitochondrial population [6] and to control mitochondrial energy metabolism, protecting cells from mitochondrial damage and maintain the overall architecture of these organelles [7, 8] .
Mitochondria are recognised as major targets of bioactive compounds, such as omega-3 polyunsaturated fatty acids (PUFAs) and flavonoids, which are found in healthy diets. The current data support a role for omega-3 PUFA supplementation, particularly docosahexaenoic acid (DHA), which is strongly associated with changes and the remodelling of mitochondrial phospholipid composition and organisational domains [9] [10] [11] [12] [13] [14] . Although DHA is a likely target for oxidation [15] [16] [17] , its health benefits are largely derived through DHA (22:6n − 3) rapidly in place of other fatty acids into biological membranes, particularly plasma and mitochondrial membranes and its cell signalling mechanisms. Incorporation of 22:6n − 3 influences membrane structure and function [18] , increasing membrane permeability [19] fluidity and plasticity altering conformational states with their acyl chains, which are extremely flexible [13] , and influences the physical properties of biological membranes, thereby altering protein function and fusion [13, 20] . In addition to being susceptible to lipid peroxidation, DHA could decrease mitochondrial function simply as a result of the accumulation of oxidised products [21] , altering the lipid bilayer and decreasing bioenergetic activities due to membrane perturbations [19] . In mitochondria, PUFAs play a role in several mitochondrial processes, including mitochondrial calcium homeostasis, gene expression, and respiratory function, and act as protonophores to reduce mitochondrial ROS production through uncoupling protein (UCP)-mediated decreases in mitochondrial membrane potential [17] .
Mitochondria can also be regarded as important intracellular targets of agents that protect from the undesirable action of ROS, such as polyphenols, which prevent against many pathological states involving oxidative cell damage [22] . Epigallocatechin-3-gallate (EGCG) is the most abundant polyphenol isolated from green tea and is widely studied because it promotes cardiovascular and metabolic health by acting as a potent antioxidant that may have therapeutic applications in the treatment of many disorders. EGCG has antioxidant properties [23] [24] [25] with powerful radical scavengers. These antioxidant activities are due to the presence of phenolic groups that are sensitive to oxidation and are increased by the presence of the trihydroxyl structure in the D ring of EGCG [26] . Therefore, the presence of antioxidants jointly with omega-3 PUFAs would prevent possible oxidative deterioration. Despite the beneficial response of EGCG and DHA in muscle cells, here, we tested the hypothesis that EGCG has protective effects on the DHA oxidation, associated to the changes of physical properties of biological membranes and consequent changes in energy metabolism due to DHA intake. Taking into account that skeletal muscle tissue is a major determinant of whole-body energy metabolism, the aim of this study was to examine how EGCG and DHA, alone or in combination, affect cell energy homeostasis, mitochondrial functionality and morphology, oxidative phosphorylation, ROS generation and calcium homeostasis in L6 myocytes.
Materials and methods

Chemicals
(−) Epigallocatechin-3-gallate (EGCG) from green tea, cis-4,7,10,13,16,19-docosahexaenoic acid (DHA), fatty acid-free BSA, 2′,7′dichlorofluorescin diacetate (DCFH-DA), DMSO, Bradford reagent, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP), oligomycin, rotenone, antimycin A, rhodamine 123 (Rhd123), ethanol, succinate and Fluo-3 acetoxymethyl ester (Fluo-3 AM) were obtained from Sigma-Aldrich (Madrid, Spain), and the MitoTracker FM was obtained from Molecular Probes (Eugene, Oregon, USA). Dulbecco's modified Eagle's medium (DMEM), glutamine, fetal bovine serum (FBS), penicillin and streptomycin were obtained from BioWhittaker (Verviers, Belgium).
Cell culture
L6 myocyte cells (kindly supplied from Dr. Manuel Portero-Otín) were routinely cultivated in DMEM supplemented with 2 mM glutamine, 10% FBS, 1% penicillin (126.6 U/mL) and 1% streptomycin (0.126 mg/mL) at 37°C in an atmosphere of 5% CO 2 . The cells were grown to approximately 80% confluence and then induced to differentiate into myotubes in DMEM supplemented with 2% FBS. After 7 days, myotube differentiation was complete, and the experimental procedure was initiated. L6 cells were serum-starved for 4 h before the assay. All experiments were performed in triplicate in 3 independent experiments.
Cell treatment
To study the effects of EGCG, DHA and the combination of both compounds on mitochondrial function, metabolism and morphology, L6 myocyte cells were treated with the vehicle control, 25 μM EGCG, 25 μM DHA, or 25 μM EGCG + 25 μM DHA. Both compounds were dissolved in ethanol and added to the culture media. The medium used during the treatment was serum-free DMEM containing 2% BSA. The experiments were performed in triplicate and with 3 different passages. The final concentration of ethanol in the media was 0.05%, a nontoxic percentage. After 4 h, the cells were used for the different analyses.
Cell death
Cell death was assessed by lactate dehydrogenase (LDH) leakage into the culture medium. Following the 24 h of exposure to EGCG and DHA (25 μM), the culture medium was aspirated and centrifuged at 3000 rpm for 5 min to obtain a cell-free supernatant; on the other hand cells were lysed in cold buffer (25 mM HEPES pH 7.0, 0.1% Triton X-100). The next steps were performed according to the manufacturer's instructions for the LDH kit (QCA; Amposta, Spain). The % of LDH leakage was normalised to control group and calculated as follows:
Oxygen consumption assay in intact cells
In vivo measurements of mitochondrial oxygen consumption with intact cells were performed using a high-resolution oxygraph (Oroboros Instruments, Innsbruck, Austria) to quantify the respiration states. L6 myocytes were treated in 6-well plates and removed from culture dishes through trypsinisation (0.05% trypsin-EDTA). After 5 min of centrifugation at 200 g (room temperature), the cells were resuspended in warmed respiration medium (DMEM without fetal bovine serum) and transferred to the corresponding respiration chamber at a concentration of 4-6 × 10 6 cells/mL. Analyses of respiration rates were performed in 2 mL of respiration medium at 37°C with stirring at 750 rpm. When the oxygen concentration was stabilised, basal respiration was recorded (Routine state) to control the levels of respiration and phosphorylation in a physiologically coupled state, which was supported by exogenous substrates in the culture media. Following stabilisation of the Routine state, ATP synthesis was inhibited with 2 μg/mL oligomycin, and the nonphosphorylating or resting state (Leak state) was recorded. Subsequently, 10-12 μM FCCP was added to stimulate respiration maximally at a level flow, measuring the electron transport system (ETS) capacity in the noncoupled state (ETS state). In sum, respiration was blocked with 2.5 μM rotenone and 2.5 μM antimycin, representing the residual oxygen consumption (ROX) state that remains after electron transport chain (ETC) inhibition. The results are expressed as oxygen flow per number of cells (pmol oxygen/10 6 cells * s). All results were corrected using the ROX state capacity. Oxygen consumption was calculated using DataGraph Software from Oroboros Instruments (Innsbruck, Austria).
Determination of ADP/ATP ratio
The total ADP/ATP ratio in the muscle cells was determined after 4 h of treatment using the ApoSENSOR™ ADP/ATP ratio assay kit (Biovision, Mountain View, CA, USA) following the manufacturer's instructions.
Intracellular ROS generation
The levels of intracellular ROS were quantified using the fluorescent probe 2′,7′-dichlorofluorescein-diacetate (DCFH-DA) [27] . A stock solution (10 mM) of DCFH was prepared in DMSO. Cells (2 × 10 6 per well) were incubated in black 24-well plates with clear bottoms. DCFH-DA diffuses into cells and becomes trapped inside the cell after being cleaved by intracellular esterases.
After treatment, the cells were washed twice with warmed PBS, and 10 μM of DCFH diluted in PBS was then loaded into the wells for 30 min at 37°C in the dark. The cells were then gently washed twice in PBS to remove the excess dye and resuspended in 0.5 mL of PBS per well. The fluorescence intensity was recorded over 4 h as a measure of the degree of cellular oxidative stress. Intracellular ROS production was measured using an FLx800 Multi-Detection Microplate Reader (BioTek, Winooski, USA) at an excitation wavelength of 485 nm and an emission wavelength of 530 nm (37°C). The measured fluorescence values are expressed as a percentage of fluorescence with respect to the control group.
Measurement of mitochondrial membrane potential (MMP)
MMP was monitored using Rhd123 dye fluorescence with an excitation wavelength of 525 nm and an emission wavelength of 485 nm using an FLx800 Multi-Detection Microplate Reader (BioTek; Winooski, USA) at 37°C. Rhd123 is a membrane-permeant cation that is strongly sequestered in mitochondria due to their negative membrane potential. If mitochondria become depolarised, Rhd 123 is redistributed from the mitochondria to the cytosol, where it becomes diluted and, as a consequence, the fluorescence increases. Therefore, a decrease in fluorescence corresponds to an increase in MMP. To perform the analysis, cells (2 × 10 6 per well) were incubated in black 24-well plates with clear bottoms. Rh123 was dissolved in ethanol as a 0.5 mM stock solution. After treatment, the cells were washed 3 times with warm PBS and permeated with a permeating solution (0.5 μg/mL digitonin, 250 mM sucrose, 1 mM EDTA, 50 mM KCl, 2 mM KH 2 PO 4 , 25 mM Tris-HCl (pH 7.4)). To initiate the assay, 6 mM of succinate and 0.5 μg/mL Rhd 123 were added to the wells. Fluorescence was recorded after the addition of 2 μg/mL oligomycin to inhibit the ATP synthase, and 10 μg/mL of FCCP was then added to visualise the complete depolarisation. The results are expressed as a % compared to the control group.
Measurement of intracellular Ca 2+ levels
Intracellular Ca 2+ was measured using the fluorescent calcium indicator Fluo-3 AM. This dye is a fat-soluble reagent, is not fluorescent and is membrane permeate. Intracellular esterases break down the Fluo-3 AM ester into acetoxymethyl and Fluo-3, which can then combine with free intracellular calcium ions. The intensity of the fluorescence is dependent on the free calcium concentration. L6 cells were treated in 24-well black plates with clear bottoms. After treatment, the cells were washed three times in standard medium (141 mM NaCl, 4.7 mM KCl, 1.8 mM CaCl 2 , 1.2 mM MgSO 4 , 10 mM glucose, 10 mM HEPES (pH 7.4)). The cells were loaded with Fluo-3 AM (5 μM) for 45 min (37°C) in the dark in the standard medium. The cells were then washed again to allow for the cleavage of the acetoxymethyl esters and resuspended in the standard medium or Ca 2+ -free solution (the same as the standard medium except for the addition of calcium). Fluorescence was measured after 30 min using an FLx800 Multi-Detection Microplate Reader (Biotek, Winooski, USA) with an excitation wavelength of 503 and emission wavelength of 526 (37°C). The Ca 2+ level is expressed as a percentage of the fluorescence intensity relative to the control group's fluorescence intensity.
RNA extraction and quantitative real-time PCR (qRT-PCR) analysis
Total RNA was obtained from L6 cells using a RNeasy Mini kit (Qiagen; Valencia, Spain) according to the manufacturer's protocol. RNA (4 μg) was reverse transcribed to complementary DNA from the total RNA using a reverse transcription reagent kit (Applied Biosystems; Madrid, Spain). Gene expression was analysed by qRT-PCR amplification using TaqMan Universal 2× PCR Master Mix (Applied Biosystems; Madrid, Spain) and a PCR 7300 system (Applied Biosystems; Madrid, Spain) according to the manufacturer's instructions.
The thermal cycling consisted of an initial step at 50°C for 2 min, followed by a polymerase activation step at 95°C for 10 min and a cycling step with the following conditions: 40 cycles of denaturation at 95°C for 15 s and annealing at 60°C for 1 min. Specific TaqMan assay-on-demand probes were used to amplify the cDNA: cyclophilin peptidylprolyl isomerase A (Ppia) (Rn00690933_m1) (used as an endogenous control gene), cytochrome c oxidase subunit V (Cox) (Rn 00821806_m1), citrate synthase (Cs) (Rn00756225_m1), ATP5A1 (ATPase) (Rn01527025_m1), adenine nucleotide translocase 1 (Ant1) (Rn 00821477_g1), uncoupling protein 3 (Ucp3) (Rn00565874_m1), uncoupling protein 2 (Ucp2) (Rn00571166_m1), manganese superoxide dismutase (MnSod) (Rn00566942_g1), mitochondrial fission 1 protein (Fiss1) (Rn01480911_m1), dynamin-related protein 1 (Drp1) (Rn00586466_m1), mitofusin 2, (Mfn2) (Rn00500120_m1), and optic atrophy 1 (Rn_00592200_m1) (Opa1). The expression levels were normalised to cyclophilin using a comparative (2 −ΔΔCt ) method.
Measurement of mtDNA/nDNA ratio
Total DNA was extracted from cells using a Qiamp DNA mini kit (Qiagen; Valencia, Spain) according to the manufacturer's instructions. The relative mitochondrial DNA (mtDNA) levels were measured by real-time PCR using the PCR 7300 system (Applied Biosystems, Madrid, Spain) and normalised by simultaneous measurement of the nuclear DNA (nDNA), (mtDNA/nDNA ratio). Primers and probes for quantitative PCR (qPCR) were designed using Primer Express (Applied Biosystems, Madrid, Spain): Nd3 mitochondrial gene (forward: 5′cttatcttttatcctcatttcaattgca-3′, reverse: 5′-gtagtgggtattggttgtttgaatc gctc-3′) and Gapdh as a nuclear gene (forward: 5′-ccagaacatcatccctg cat-3′; reverse: 5′-gttcagctctgggatgacctt-3′).
PCR conditions were 95°C for 15 min, followed by 40 cycles of 95°C for 15 s, and 60°C for 60 s. The threshold cycle number (Ct) values for mitochondrial NADH-dehydrogenase subunit 3 (Nd3) and glyceraldehydes-3-phosphate dehydrogenase (Gapdh) were determined. The results were calculated from the difference in threshold cycle (ΔC t ) values for mtDNA and nuclear-specific amplification.
Measurement of mitochondrial morphology
To determine the mitochondrial morphology of individual cells, L6 myocytes were grown on coverslips inside 6-well collagen-treated plates filled with the appropriate culture medium. After treatment, the media was removed from the dish, and the cells were washed 3 times with prewarmed PBS. The cells were stained and incubated at 37°C for 30 min with 400 nM MitoTracker Green FM. After staining cells were washed twice in PBS. The solution was then replaced with fresh media, and the cells were coverslipped for fluorescence microscopy to examine their morphology. Confocal images were obtained using a confocal laser-scanning microscope (NIKON TE-2000; Tokyo, Japan) with a 60× objective. MitoTracker Green FM preferentially accumulates in mitochondria regardless of the mitochondrial membrane potential and provides an accurate assessment of mitochondrial mass. For the quantification of mitochondrial morphology, mitochondrial length was measured and grouped into three categories as follows: short type (1 μm ≤ in length), medium rod type (1-2 μm in length) and long type (N2 μm) using Image J software. Results are shown as a percentage of the total number mitochondria counted per treatment.
Statistical analyses
The results are expressed as the mean ± SEM of 6 animals. SPSS Statistics version 19 software (SPSS Inc., Chicago, IL, USA) was used for statistical analyses. Significant differences were analysed using oneway analysis of variance (ANOVA) followed by Tukey's post-hoc test. A p-value ≤ 0.05 was considered statistically significant.
Results
3.1. DHA increases the ADP/ATP ratio in addition to lowering oxygen consumption in intact L6 cells even when combined with EGCG Cell death did not change when cells were treated with the selected physiological concentration of 25 μM for EGCG and DHA, as assessed by % LDH leakage (Fig. 1) . Fig. 2 presents the changes in respiration caused by the different treatments in Routine, Leak and ETS states. The Routine state ( Fig. 2a ) controls physiological respiration through the cellular energy demand and is supported by the substrates in the culture media. Here, in the Routine state, despite neither EGCG nor DHA modified cell viability, treatment with DHA or DHA + EGCG for 4 h significantly reduced the oxygen consumption of the L6 cells, whereas there were no significant differences in oxygen consumption between the EGCG and control groups. By measuring the respiration rate in the presence of oligomycin, an ATPase inhibitor that is a direct measure of uncoupled respiration (Leak state) in situ (Fig. 2b) , it has been shown that in the DHA and EGCG + DHA groups, oxygen consumption was significantly decreased. In addition in the ETS state ( Fig. 2c) , in the presence of FCCP, an uncoupler to measure the maximal respiratory capacity, a decrease in the DHA and EGCG + DHA groups compared to the control and EGCG groups was evident, though not statistically significant. Fig. 2d presents a representative trace for the oxygen concentration in the chamber. This chart shows the differences between the groups in terms of the oxygen consumed in the different states and dependent on the treatment used. It clearly indicates that the DHA group tends to consume less oxygen during all recording states, especially in ETS states.
Moreover, the ADP/ATP ratio ( Fig. 3 ) that refers to the energy status of cells was significantly higher in the DHA group and significantly lower in the EGCG group, whereas in the EGCG + DHA group, the ADP/ATP ratio was similar to that of the control group.
EGCG reverses the increase of intracellular ROS caused by DHA treatment
The treatment with 25 μM DHA for 4 h significantly increased (150%) the intracellular ROS levels (Fig. 4) compared to the control and EGCG groups. In contrast, treatment with 25 μM DHA concomitant with 25 μM EGCG attenuated and reversed the increase in ROS levels induced by DHA.
DHA downregulates genes related to mitochondrial function, upregulates MnSod in parallels with Ucps, which maintained upregulation with EGCG cotreatment
The effects of DHA, EGCG and DHA + EGCG on the mRNA gene expression of marker enzymes of mitochondrial functionality are shown in Table 1 . As in the respiration analyses, treatment with 25 μM EGCG did not induce a change in mitochondrial gene expression. In the case of 25 μM DHA treatment, Cs and ATPase gene expression did not differ between the groups. In contrast, Cox and Ant1 gene expression were downregulated compared to the control group; however, Cox and Ant1 were not downregulated when the cells were treated with DHA concomitant with EGCG. Both uncoupling protein genes (Ucp2 and Ucp3) are expressed in muscle cells and were significantly upregulated in the DHA and EGCG + DHA groups. In examining the antioxidant system of the mitochondria, MnSod gene expression was significantly upregulated by DHA treatment compared to the control, but not in the co-treatment group. Fig. 5 shows the results for the MMP measurements, there was a significant increase in arbitrary fluorescence unit (AFU) values for the DHA treatment with respect to the control conditions, indicating a decrease in the membrane potential. On the other hand intracellular calcium was elevated in DHA treatment with the presence of Ca 2+ in the medium (Fig. 6a ). This elevation was not produced when a Ca 2+ -free solution was used (Fig. 6b ).
DHA decreases mitochondrial membrane potential simultaneously with an increase of intracellular Ca 2+ levels
DHA and EGCG + DHA increase mtDNA and downregulate enzymes involved in mitochondrial dynamics
Dynamin-related GTPases mediate the fission and fusion of mitochondrial membranes. In the outer membrane, Mfn1and Mfn2, are involved in the dynamic formation of the mitochondrial network. Similarly, Opa1, which is in the inner membrane, controls mitochondrial membrane fusion, whereas Drp1 and Fiss1 trigger fission events [28] .
The results of how EGCG and/or DHA compounds modulated the expression of genes implicated in mitochondrial dynamics are shown in Table 2 .
The mRNA contents of both Fiss1 and Drp1 were reduced in response to DHA and EGCG + DHA compounds, thus DHA treatment seems to prevent mitochondrial fission.
Likewise, Mfn2 that takes part in mitochondrial fusion was significantly downregulated with the DHA treatment compared to the control group; however, in terms of Opa1 expression, there were no significant differences between the groups. On the other hand, although the mRNA levels of fusion and fission gene expression are being downregulated by DHA, as shown in Fig. 7 the relative amount of mtDNA undergoes a significant 58% increase in the DHA-treated cells compared to the control group. Moreover, in the EGCG + DHA group, there was also an increase of approximately 61% compared with the control group.
Mitochondrial morphology after the DHA and EGCG treatments
To investigate whether EGCG and DHA directly alter mitochondrial dynamics, a morphological analysis was performed using fluorescence microscopy with the mitochondrial mass marker MitoTracker Green FM, which provided information about mitochondrial organisation and dynamics in L6 myocytes. Fig. 8a and e shows that the L6 control cells exhibited tubular networks with a higher proportion of round spheres, medium mitochondrial length and stubby mitochondria. After EGCG treatment ( Fig. 8b and e ), the mitochondrial morphology was similar to the control groups, with round spheres and medium length shapes. In contrast, the mitochondrial morphology after DHA treatment (Fig. 8c ) was shifted toward a fragmented mitochondria with a discontinuous network and with a higher proportion of large and elongated mitochondria. Despite changes in mitochondrial visual morphology in DHA treatment there was an increase of medium mitochondria (Fig. 8e ). Co-treatment with EGCG ( Fig. 8d) and DHA reversed the mitochondrial fragmentation, restoring the mitochondrial network with an increase in elongated mitochondria, and rounder mitochondria with short and medium lengths (Fig. 8e ).
Discussion
The beneficial effects of PUFAs against obesity and cardiovascular diseases have been well described [29, 30] . Moreover polyphenols have also been demonstrated to exhibit a variety of beneficial biological properties, also including obesity and cardiovascular disease [31, 32] . Especially DHA, as a normal component of the human diet could perform unusual shapes that could impact packing and hence membrane structure and properties that affect cellular function including signalling pathways, that may explain the wide variety of reported health benefits of n − 3 PUFAs [33] . But it is important to note that their structure with six double bounds is highly susceptible to oxidation. In this sense, other authors have reported that DHA-enriched cells are more susceptible to oxidative insult, resulting in an exacerbation of ROS generation [34] and depending on the concentrations and conditions used, some responses could be affected, so it will be useful to protect these cells with antioxidants [35] . The main objective then is to test if EGCG, a well-known potent antioxidant, could reverse and avoid cellular oxidative damage related to DHA.
In aerobic organisms, approximately 85-90% of cellular oxygen is consumed by mitochondria to produce energy in the form of ATP molecules, concomitant with the formation of ROS. ROS induce chemical modifications in other molecules, generating oxidative damage, regulating signal transduction components, and acting as second messengers for various physiological and pathological stimuli [36] . We wanted to study the effects of DHA and EGCG at the level of mitochondrial dynamics and bioenergetics in muscle cells. Results suggest that although the DHA compound is not toxic to the cells, this compound leads to altered mitochondrial dynamics, with subsequent changes in mitochondrial function, including alteration in respiration and ROS generation.
The results from the in vivo oxygen consumption assay indicate that substrate oxidation was decreased in the Routine and Leak states, by the DHA and EGCG + DHA treatments. In addition, DHA-treated cells clearly consumed less oxygen during the entire recording protocol. A few studies have used dietary fish oil to investigate the influence of omega-3 PUFAs on mitochondrial respiration and have reported either no change or decreases during some measurements of various substrates [19, 37] . Here, with the decrease in mitochondrial respiration, mitochondrial functionality was also affected. DHA may have contributed as a potent deregulator of O 2 consumption and oxidative phosphorylation with the decreasing bioenergetic activities being, in part, due to the result of membrane perturbations caused by DHA [19] .
The incubation of L6 myocytes with 25 μM DHA for 4 h led to an increase (150%) in intracellular ROS production without causing loss of cell viability. This result is in agreement with the interaction or incorporation of added DHA into the cell membrane phospholipid composition [38, 39] and the susceptibility of most omega-3 PUFAs to produce oxidative damage in cells [40] . In addition, many lipid peroxidation products are themselves very potent ROS producers that can induce considerable damage to other biological molecules [37] . However oxidative stress from ROS could be a cause and a consequence of the observed mitochondrial alteration and addresses the possibility that ROS precede DHA changes in mitochondrial dysfunction. The increased ROS levels in the DHA group led to MnSod overexpression, which is one of the primary antioxidant responses to elevated ROS production [41, 42] a part from the Ucp3 overexpression during DHA treatment that might also protect myocytes from ROS already described in mouse myotubes under oxidative stress conditions [43] . Moreover the DHA cell treatment increased ADP/ATP ratio with a downregulation of Ant1 gene expression, which blocked the exchange of ADP and ATP across the mitochondrial inner membrane and disrupted the energy homeostasis, concomitant with lowered mitochondrial functionality through ETC and oxidative phosphorylation (OXPHOS) system disruptions, with Cox gene downregulation and the decrease of the oxygen consumption with low respiratory capacity with the incapacity to increase respiration upon the addition of FCCP shown in the DHA treatment, as other authors have reported [44] [45] [46] . The impairment in mitochondrial functionality was reversed in the EGCG + DHA group, whereas the ROS levels remained at the same levels as the control cells, which is consistent with the role of EGCG as a potent antioxidant [47] and as an uncoupler-like [48] compound, decreasing ROS production. The polyphenol structure of EGCG facilitates its capacity to penetrate membranes, resulting in ROS scavenging between the mitochondrial membrane and matrix [49] . It is important to emphasise that the overexpression of Ucp2 and Ucp3 was maintained in the DHA + EGCG group because, despite the antioxidant effects of EGCG, DHA was still present in the culture media. Furthermore, mitochondria also participate in intracellular Ca 2+ homeostasis via several Ca 2+ uptake and release pathways, and ROS production could affect Ca 2+ homeostasis due to the deterioration of membranes that contain the intracellular Ca 2+ stores [50, 51] . The results from the present study reveal that the DHA treated cells displayed higher intracellular Ca 2+ levels when Ca 2+ was supplemented in the culture media. Accordingly, it appears that the high levels of ROS produced by DHA membrane incorporation or through alterations of the cell membrane phospholipid composition induced a calcium influx of external calcium that was not from mitochondria or other calcium stores.
Mitochondrial metabolic changes could be produced by the variation in membrane fatty acid composition that is linked with the respiratory activity and OXPHOS functionality, so the downregulation of fission (Fiss1, Drp1) and fusion (Mfn2) gene expression during DHA treatment is a mechanism to compensate mitochondrial function and to restore mitochondrial tubules [8] maintaining freedom for both fusion and fission that is a fundamental factor to ensure adequate bioenergetics utility of the mitochondria.
Another compensatory mechanism is the higher mtDNA/nDNA ratio of the DHA-treated cells, suggesting that endogenous and exogenous oxidative stresses are factors involved in the increase of the mitochondrial abundance and mtDNA copy number in human and animal cells [3] , resulting from a feedback response that compensates for defective mitochondria, hallmarks of an impaired respiratory chain or mutated mtDNA [52] . The Fiss1 and Drp1 gene expression were also downregulated with more rounded and elongated, short and medium length mitochondria developing functional machineries and restoring mitochondrial tubules [4, 53, 54] in the EGCG + DHA group. This inhibition of fission events could also repair mitochondrial damage that allows the mixing of mtDNA from other mitochondria becoming more elongated. Moreover endogenous respiration in the Routine state was also low concomitantly with altered mitochondrial morphology and cellular bioenergetic dynamics as other authors had reported [55] [56] [57] , and similar to the DHA group, due to the PUFA-containing mitochondrial membranes [46] which leads to oxidative damage. In addition, it has previously been demonstrated that Drp1 downregulation in HeLa cells leads to slower cell growth, ETC uncoupling, decreased cellular respiration and increased ROS levels [55] , as what occurred here in L6 myocytes after DHA treatment. Mitochondrial morphology images reveal that in DHA treatment the majority of the mitochondria were large, elongated with some fragmented compared to control cells, as described in 3T3-L1 adipocyte studies [58, 59] and could be caused by the downregulation of Fiss1 and Drp1 gene expression as described in rat skeletal muscle studies [60] . In addition, this deregulated mitochondrial morphology might lead to alterations in oxidative phosphorylation [8, 61] as we had been shown in cells treated with DHA, although the imbalance in mitochondrial architecture in this situation revealed that mitochondria are able to adjust their own metabolism, to keep the cell alive; that is what we call adaptive response to understand mitochondrial physiology. The data presented fit our hypothesis indicating that the antioxidant and uncoupling abilities of EGCG mentioned above, influence mitochondrial morphology, reduce DHA intracellular ROS overproduction, and alter the ADP/ATP ratio and expression of Cox and Ant1 genes to control levels.
In conclusion, the combination of DHA + EGCG could be a good choice for avoiding and correcting the possible deleterious effects of DHA.
